BFC Planning’s Caris Life Sciences CAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$980 Hold
32
– – ﹤0.01% 3165
2026
Q2
$570 Hold
32
– – ﹤0.01% 3235
2026
Q1
$572 Buy
32
+17
+113% +$372 ﹤0.01% 2838
2025
Q4
$405 Buy
+15
New +$422 ﹤0.01% 2953

Other funds holding CAI

BFC Planning's CAI Position: Q3 2026 in Review

BFC Planning held its Caris Life Sciences (CAI) position steady in Q3 2026 at 32 shares worth $980. The position accounts for ﹤0.01% of the portfolio, ranked #3165.

BFC Planning first reported a position in CAI in Q4 2025 and has held it in 4 quarters since. 252 funds tracked by Wall St. Rank hold CAI as of Q3 2026.

  • BFC Planning held 32 shares of Caris Life Sciences worth $980 as of Q3 2026.
  • BFC Planning left its Caris Life Sciences share count unchanged in Q3 2026.
  • Caris Life Sciences made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3165 holding.
  • BFC Planning first reported a position in Caris Life Sciences in Q4 2025 and has held it in 4 quarters since.
  • 252 funds tracked by Wall St. Rank held Caris Life Sciences as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.